Guggenheim Capital’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
KCM
Guggenheim Capital's LEGN Position: Q3 2026 in Review
Guggenheim Capital increased its Legend Biotech (LEGN) stake by 32% in Q3 2026, buying an estimated $181K and bringing the position to 34,680 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.
Guggenheim Capital first reported a position in LEGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.9M in Q4 2023. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.
- Guggenheim Capital held 34,680 shares of Legend Biotech worth $690K as of Q3 2026.
- Guggenheim Capital bought 8,491 Legend Biotech shares in Q3 2026, an estimated $181K.
- Legend Biotech made up ﹤0.01% of Guggenheim Capital's portfolio in Q3 2026, its #1114 holding.
- Guggenheim Capital first reported a position in Legend Biotech in Q4 2023 and has held it in 12 quarters since.
- Guggenheim Capital's Legend Biotech position peaked at $1.9M in Q4 2023.
- 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.
Based on Guggenheim Capital's 13F filing for Q3 2026, filed 16 Nov 2026.